Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas

Ameloblastoma is a common and unpredictable odontogenic tumor with high relapse rates. Several studies assessing the proliferative capacity of these neoplasms have been published, mainly using the protein Ki-67. Cell counts must be completed to determine the cell proliferation rate. Multiple methods have been developed for this purpose. The most widely used method is the labeling index, which has undergone changes over time to better facilitate cell counting. Here, we compared manual cell counting methods with automated cell counting (ImmunoRatio) to determine the relative effectiveness of these methods. The results suggest that ImmunoRatio, a free software tool, may be highly advantageous and provide results similar to manual cell counting methods when used with the appropriate calibration. However, ImmunoRatio has flaws that may affect the labeling index results. Therefore, this automated cell counting method must be supplemented with manual cell counting methods.

[1]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[2]  R. Gónzalez-Gónzalez,et al.  Immunohistochemical Expression of Survivin and Its Relationship with Cell Apoptosis and Proliferation in Ameloblastomas , 2015, Disease markers.

[3]  K. R. Rao,et al.  A comparison of manual and automated methods of quantitation of oestrogen/progesterone receptor expression in breast carcinoma. , 2015, Journal of clinical and diagnostic research : JCDR.

[4]  Ali Bijani,et al.  A comparative study of PCNA and Ki-67 expression in dental follicle, dentigerous cyst, unicystic ameloblastoma and ameloblastoma , 2013, International journal of molecular and cellular medicine.

[5]  H. Coleman,et al.  Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[6]  D. Perez,et al.  Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. , 2010, International journal of oral and maxillofacial surgery.

[7]  M. Irigoyen-Camacho,et al.  Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. , 2008, Oral oncology.

[8]  R. Mesquita,et al.  Odontogenic tumors: a study of 340 cases in a Brazilian population. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  Vilppu J. Tuominen,et al.  Grading of Neuroendocrine Tumors With Ki-67 Requires High-quality Assessment Practices , 2012, The American journal of surgical pathology.

[10]  G. Ramos,et al.  Odontogenic tumors: a 14-year retrospective study in Santa Catarina, Brazil. , 2014, Brazilian oral research.

[11]  N. Molina-Frechero,et al.  An easy cell counting method for immunohistochemistry that does not use an image analysis program , 2011, Histopathology.

[12]  R. Metgud,et al.  Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor. , 2013, Annals of diagnostic pathology.

[13]  A. Stepan,et al.  The evaluation of p16 and Ki67 immunoexpression in ameloblastomas. , 2014, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[14]  M. Amin,et al.  EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence , 2012, Diagnostic Pathology.

[15]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[16]  Ramón G Carreón-Burciaga,et al.  Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns , 2015, Disease markers.

[17]  Vilppu J Tuominen,et al.  ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 , 2010, Breast Cancer Research.